Home/Investors/Korea Investment Partners (KIP)

Korea Investment Partners (KIP)

Biotech Investor · 2 portfolio companies

Portfolio

2

Focus Areas

6

Top Stage

platform

Investment Focus

Oncology Immunology Metabolic Disorders Diabetes Muscular Wasting Obesity

Portfolio Companies

Company	Stage	Valuation	Focus
Zencore Biologics	platform	—	Oncology, Immunology
Atrogi	Phase 2	—	Metabolic Disorders, Diabetes

Frequent Co-Investors

Qiming Venture Partners1 shared LYFE Capital1 shared Goldman Sachs Asset Management1 shared Sofina1 shared Novo Holdings1 shared IDG Capital1 shared GT Capital1 shared Cowin Capital1 shared